US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
カナダ
TSXV
Genix Pharmaceuticals Corp (GENX) 銘柄情報

Genix Pharmaceuticals Corp (GENX)

0.015

0.00

(0.00%)

終了 6月21日 5:00AM

Genix Pharmaceuticals Corp (GENX) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.015

( - )

買値

0.015

売値

0.02

出来高

-

0.00 日の範囲 0.00

0.015 52 週間の範囲 0.04

時価総額

前日終値

0.015

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

$ 9,000

発行済株式数

61,224,131

配当利回り

PER

-3.22

1 株当たり利益 (EPS)

-0

歳入

-

純利益

-279.44k

Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with a focus on nutraceuticals and pharmaceuticals in Canada. The company offers generic ophthalmic prescription products, ophthalmic nutraceutical formulations, and prescription generic ... Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with a focus on nutraceuticals and pharmaceuticals in Canada. The company offers generic ophthalmic prescription products, ophthalmic nutraceutical formulations, and prescription generic drugs; ophthalmic OTC products; and eye ointments and drops. It also provides Flu-X, an anti-viral, anti-flu, and common colds coronavirus oral and spray herbal product; Rechlor, a dietary supplement to support kidney health; Sucanon, an herbal health supplement to manage blood sugar levels and enhance insulin sensitivity in non-insulin dependent adults; and Synthroid, a levothyroxine sodium drug for the treatment of hypothyroidism. The company was formerly known as Alta Natural Herbs & Supplements Ltd. and changed its name to Genix Pharmaceuticals Corporation in June 2019. Genix Pharmaceuticals Corporation was incorporated in 1993 and is based in Vancouver, Canada. 詳細を表示

セクター

Healthcare

業界

Pharmaceuticals

ウェブサイト

genixpharm.com

本社

Vancouver, Canada

設立

1993

Genix Pharmaceuticals Corp is listed in the Healthcare sector of the トロントベンチャー取引所 with ticker GENX. The last closing price for Genix Pharmaceuticals was $0.02. Over the last year, Genix Pharmaceuticals shares have traded in a share price range of $ 0.015 to $ 0.04.

Genix Pharmaceuticals currently has 61,224,131 shares in issue. The market capitalisation of Genix Pharmaceuticals is $918,361.97 . Genix Pharmaceuticals has a price to earnings ratio (PE ratio) of -3.22.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0.015	0.015	0.015	0	0	CS
4	0	0	0.015	0.015	0.015	450	0.015	CS
12	-0.005	-25	0.02	0.02	0.015	172	0.0155	CS
26	-0.01	-40	0.025	0.025	0.015	5635	0.02009455	CS
52	-0.025	-62.5	0.04	0.04	0.015	13584	0.02764931	CS
156	-0.04	-72.7272727273	0.055	0.09	0.015	8126	0.03650007	CS
260	-0.19	-92.6829268293	0.205	0.25	0.015	8727	0.08171059	CS

GENX - Frequently Asked Questions (FAQ)

What is the current Genix Pharmaceuticals Corp share price?

The current share price of Genix Pharmaceuticals Corp is $ 0.015

How many Genix Pharmaceuticals Corp shares are in issue?

Genix Pharmaceuticals Corp has 61,224,131 shares in issue

What is the market cap of Genix Pharmaceuticals Corp?

The market capitalisation of Genix Pharmaceuticals Corp is CAD 918.36k

What is the 1 year trading range for Genix Pharmaceuticals Corp share price?

Genix Pharmaceuticals Corp has traded in the range of $ 0.015 to $ 0.04 during the past year

What is the PE ratio of Genix Pharmaceuticals Corp?

The price to earnings ratio of Genix Pharmaceuticals Corp is -3.22

What is the registered address of Genix Pharmaceuticals Corp?

The registered address for Genix Pharmaceuticals Corp is 1055 West Hastings Street, Vancouver, British Columbia, V6E 2E9

What is the Genix Pharmaceuticals Corp website address?

The website address for Genix Pharmaceuticals Corp is genixpharm.com

Which industry sector does Genix Pharmaceuticals Corp operate in?

Genix Pharmaceuticals Corp operates in the Pharmaceuticals sector

tkg

IQM Quantum Computers (founded in 2018, headquartered in Finland) is a global leader in building full-stack, on-premises superconducting quantum computers. They design their own processor chips and provide systems for research labs, high-performance computing centers (HPC), and enterprises worldwide

tkg

Dr. Craig Ciesla joining IQM Quantum Computers as Chief Technology Officer (CTO) is a notable positive driver for Lightwave Logic, Inc. (NASDAQ: LWLG). As an independent director on the Lightwave Logic Board of Directors, his elevated visibility and influence in the quantum computing ecosystem offer

joe_techi

joe_techi 40分前

Wall Of Voodoo - Me And My Dad
https://www.youtube.com/watch?v=lWvPoamMIwQ

Investor2014

Investor2014 48分前

Many of the core criticisms are directionally supported by later events and primary documents, but the report also uses inflammatory language, overstates some legal conclusions, conflates Alzheimer's and Rett syndrome at points, and treats negative interpretations as established facts.

Investor082

Investor082 1時間前

Gary,

This is a nice post to go into the record books, LOL! We will check in every quarter to measure progress.

The only problem is you, Flipper, and other minions predicted $23+ share price back in 2022. 4 years later, the two of you and other minions have missed by

Investor082

Investor082 1時間前

While the shareholders got decimated and will continue to get destroyed going forward, LOL! ;)

Any update on the 10 year survival data for NICE?

eagle8

eagle8 1時間前

Doc logic,

we have already seen and read many discussions about the costs NICE is willing/able to pay for DCvax.
If you look at the NEW costs for NICE after approval for DCvax, surely you can state:
Chemo expenses are being minimized and DCvax is being introduced.

Tdl9586

Tdl9586 1時間前

are you going to vote ? and how are you going to vote ?

Seminole Red

Seminole Red 2時間前

theres alot of big names on the board, I dont think its going to matter unless Clark Chokes and 2 or 3 others step up.....as Fitz should say, 'Dont fall down like me....

Kam8

Kam8 2時間前

HI Skitahoe

The most important thing is LP prepared 900M share suddenly.

I am praying BP would pay $8+ for those 900shares.

Or MRK acquire nwbo with $30 Billion suddenly. (Merger)

rocketeer357

rocketeer357 2時間前

That rent on Freddy is way too high. And the roles are reversed. We're the team that guts farm systems by trading players in their walk year. You're one of the teams that trades the farm for the walk year guys. We can't afford to pay players 20 million plus per year if they don't play. You can and d

fuagf

fuagf 2時間前

He being a decent wind player as we read, he just had a bad day, is all.

Seminole Red

Seminole Red 2時間前

Henly is a top fairway hitter too and strings pars forever, usually .... theres no trees on this course to block the wind

fuagf

fuagf 2時間前

Yep. On Henley though, as thought could be;

Russell Henley is widely regarded as one of the best wind and adverse-condition players on the PGA Tour.

https://www.google.com/search?q=pga+stats+-+how+is+henley+in+the+wind+&client=firefox-b-d&hs=rwRV&sca_esv=77e9a8666bf485

Seminole Red

Seminole Red 2時間前

I guess if you look back on history the US Open has always been a tough venue wherever its played

DocLee

DocLee 3時間前

Hi, Dedugan. I share the frustration that you and many (?most?) others feel at the extended wait that we are all are experiencing for the MAA to be approved.

However, I don't think that your concern - "why can't MHRA approve it for use at the patient's and physician's discretion and

Wayne R

Wayne R 3時間前

Yup, the new reality isn't buying or selling based on fundamentals, it's, baah, why not. Follow the sheep 🐑

sony12

sony12 3時間前

Is Klug in jail ?

DoF

Or maybe to spend more time on his other pusuits, like
Digialage Inc (Peter Michaels, President)
SocialSafe Inc (Peter Michaels, President and Director, Neal Newgard & Awan D Nord, Directors)
ThaHOUSE Inc (Ian Caloun, President, Peter Michaels, Director)

Ammarmalhas

Ammarmalhas 3時間前

Sleven,
I have been reading the back and forth exchange between you guys and I can only say it is a very healthy and important exercise that enriches this ongoing discussion and the whole forum.
Please do not stop posting and please continue your well appreciated intervention in the di

Mr.anderson1

Mr.anderson1 3時間前

MEHA's Defense Strategy Before the PanelTo avoid permanent delisting, MEHA's legal and executive teams must present a definitive plan to the Panel demonstrating how they will quickly lift the share price back over the $1.00 threshold. Their primary arguments will rely on two primary elements: [https

G-star 3時間前

The BOD per co-founder ZUBCEVIK has stated Mayer is no longer with the company. Eric Nelson, PhD has been appointed CEO.

So according to your post, Ken Mayer was CEO on June 17th.
According to another,he was already gone and replaced. That’s not a ‘positive development’ ,that’s

fuagf

fuagf 3時間前

Looks like it, but how many do. Guessing he is like most everyone, rather have calm, and that +10 was a real exception, in that he just had a terrible day because we were counting on him doing his more usual thing. Chuckle, ignore the last 11 words there.

Genz2

Genz2 3時間前

It’s hard to believe that the CEO of Crowdstrike, George Kurtz’s net worth is more than Satya Nadella, CEO of Microsoft!!! Especially when Wave and Microsoft’s cybersecurity is so much better than Crowdstrike’s!!!!

FanOfspringsteen

FanOfspringsteen 3時間前

Genix Pharmaceuticals

Golden Arrow Resources

Citigroup Global Markets...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。